Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation - Quiz - MDSpire

Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation

  • By

  • Nada A. Almarghalani

  • Magdah A. Ganash

  • Mona G. Alharbi

  • Tareq Abualfaraj

  • Almohanad A. Alkayyal

  • Ahmad Bakur Mahmoud

  • July 13, 2026

Share

Original Source(s)

Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation

  • by Nada A. Almarghalani, Magdah A. Ganash, Mona G. Alharbi, Tareq Abualfaraj, Almohanad A. Alkayyal, Ahmad Bakur Mahmoud

  • July 13, 2026

Related Content

KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis

Topical trichloroacetic acid versus electrocautery for treatment of anal intraepithelial neoplasia in people living with HIV: a multicentre, randomised, non-inferiority trial (TECAIN-study)

A metabolic marker–based diagnostic model for precancerous and malignant endometrial lesions in insulin-resistant PCOS women with sonographically suspected endometrial polyps